PRODUCT DELIVERY MECHANISM ISSUE

This adverse event was reported 5382 times

These drugs are most commonly taken by patients reporting PRODUCT DELIVERY MECHANISM ISSUE:

# Drug Count
0 ALIROCUMAB 608
1 ALBUTEROL SULFATE 553
2 FLUTICASONE PROPIONATE 340
3 AZELASTINE 339
4 AZELASTINE HYDROCHLORIDE 317
5 FLUTICASONE PROPIONATE NASAL 270
6 VARENICLINE 252
7 IPRATROPIUM BROMIDE 207
8 PERFLUOROHEXYLOCTANE 201
9 CYCLOSPORINE 178
See all common drugs associated with PRODUCT DELIVERY MECHANISM ISSUE

PRODUCT DELIVERY MECHANISM ISSUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 WHITE PETROLATUM MINERAL OIL 4 0.1379
1 PERFLUOROHEXYLOCTANE 201 0.0865
2 ALIROCUMAB 608 0.0236
3 OLOPATADINE HYDROCHLORIDE AND MOMETASONE FUROATE 46 0.0226
4 FLUOROMETHOLONE ACETATE 6 0.0225
5 IPRATROPIUM BROMIDE AND ALBUTEROL 58 0.0210
6 BRIMONIDINE TARTRATE AND TIMOLOL MALEATE 8 0.0202
7 LATANOPROSTENE BUNOD 23 0.0201
8 ADALIMUMAB-ADBM 5 0.0187
9 AZELASTINE 339 0.0182
See all drugs enriched for association with PRODUCT DELIVERY MECHANISM ISSUE

PRODUCT DELIVERY MECHANISM ISSUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Semifluorinated Alkane [EPC] 201 0.0865
1 PCSK9 Inhibitor [EPC] 612 0.0238
2 Oxaborole Antifungal [EPC] 1 0.0143
3 Calcitonin [EPC] 42 0.0134
4 Ectoparasiticide [EPC] 43 0.0110
5 Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] 130 0.0079
6 Androgen [EPC] 155 0.0057
7 Sulfone [EPC] 59 0.0054
8 Polyene Antimicrobial [EPC] 2 0.0049
9 Interleukin-5 Antagonist [EPC] 3 0.0044
See all drug classes enriched for association with PRODUCT DELIVERY MECHANISM ISSUE